You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 35 No. 12, December 1978 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Toward a Biochemical Classification of Depressive Disorders

I. Differences in Urinary Excretion of MHPG and Other Catecholamine Metabolites in Clinically Defined Subtypes of Depressions

Joseph J. Schildkraut, MD; Paul J. Orsulak, PhD; Alan F. Schatzberg, MD; Jon E. Gudeman, MD; Jonathan O. Cole, MD; William A. Rohde, MD; Richard A. LaBrie, PhD

Arch Gen Psychiatry. 1978;35(12):1427-1433.


Abstract

• The urinary excretion of 3-methoxy-4-hydroxyphenylglycol (MHPG) and other catecholamine metabolites was measured in a series of 63 patients with various clinically defined subtypes of depressive disorders. MHPG excretion was significantly lower in patients with bipolar manic-depressive depressions and schizoaffective depressions than in patients with unipolar nonendogenous depressions. Patients with schizophrenia-related depressions also excreted reduced levels of MHPG when compared with patients with unipolar nonendogenous depressions. Moreover, levels of urinary epinephrine and metanephrine were significantly lower in patients with schizophrenia-related depressions. These data, coupled with our recent finding that patients with schizophrenia-related depressions had significantly higher levels of platelet monoamine oxidase activity than control subjects or patients with unipolar endogenous depressions, suggest that we can discriminate three biochemically discrete subgroups of depressive disorders corresponding to the following clinically defined subtypes: (1) the bipolar manic-depressive depressions plus the schizo-affective depressions; (2) the unipolar nonendogenous depressions; and (3) the schizophreniarelated depressions.



Author Affiliations

From the Department of Psychiatry, Harvard Medical School, Boston (Drs Schildkraut, Orsulak, Schatzberg, Gudeman, Cole, and Rohde); the Neuropsychopharmacology Laboratory (Drs Schildkraut and Orsulak) and the Department of Adult Services (Dr Gudeman), Massachusetts Mental Health Center, Boston; the Departments of Psychiatry (Drs Schatzberg and Rohde) and Psychopharmacology (Dr Cole), McLean Hospital, Belmont, Mass; and LaBrie Associates, Cambridge, Mass (Dr LaBrie).


Footnotes

Accepted for publication May 10, 1978.

Reprint requests to Massachusetts Mental Health Center, 74 Fenwood Rd, Boston, MA 02115 (Dr Schildkraut).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Reduced Brain Norepinephrine and Dopamine Release in Treatment-Refractory Depressive Illness: Evidence in Support of the Catecholamine Hypothesis of Mood Disorders
Lambert et al.
Arch Gen Psychiatry 2000;57:787-793.
ABSTRACT | FULL TEXT  

Carbamazepine-Induced Up-regulation of Voltage-dependent Na+ Channels in Bovine Adrenal Medullary Cells in Culture
Yoshimura et al.
J. Pharmacol. Exp. Ther. 1998;287:441-447.
ABSTRACT | FULL TEXT  

Urinary Excretion of Catecholamines and Their Metabolites in Relation to Circulating Catecholamines: Six-Hour Infusion of Epinephrine and Norepinephrine in Healthy Volunteers
Moleman et al.
Arch Gen Psychiatry 1992;49:568-572.
ABSTRACT  

Possible Subtypes of Affective Disorder Suggested by Differences in Cerebral Laterality and Testosterone: A Preliminary Report
Wexler et al.
Arch Gen Psychiatry 1989;46:429-433.
ABSTRACT  

Toward a Biochemical Classification of Depressive Disorders: X. Urinary Catecholamines, Their Metabolites, and D-Type Scores in Subgroups of Depressive Disorders
Schatzberg et al.
Arch Gen Psychiatry 1989;46:260-268.
ABSTRACT  

Predictors of Drug Response in Depression
Joyce and Paykel
Arch Gen Psychiatry 1989;46:89-99.
ABSTRACT  

High Intercorrelations Among Urinary Outputs of Norepinephrine and Its Major Metabolites: A Replication in Depressed Patients and Controls
Roy et al.
Arch Gen Psychiatry 1988;45:158-161.
ABSTRACT  

The Differential Diagnosis of Depression: Relevance of Positron Emission Tomography Studies of Cerebral Glucose Metabolism to the Bipolar-Unipolar Dichotomy
Schwartz et al.
JAMA 1987;258:1368-1374.
ABSTRACT  

Afternoon Continuous Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol and Age: Distinctive Biologic Subgroups of Endogenous Depression?
Halbreich et al.
Arch Gen Psychiatry 1987;44:804-812.
ABSTRACT  

Catecholamine Metabolism and Disposition in Healthy and Depressed Subjects
Maas et al.
Arch Gen Psychiatry 1987;44:337-344.
ABSTRACT  

Lithium Carbonate Treatment of Mania: Cerebrospinal Fluid and Urinary Monoamine Metabolites and Treatment Outcome
Swann et al.
Arch Gen Psychiatry 1987;44:345-354.
ABSTRACT  

Electroencephalographic Sleep in Psychotic Depression: A Valid Subtype?
Thase et al.
Arch Gen Psychiatry 1986;43:886-893.
ABSTRACT  

Urinary 3-Methoxy-4-Hydroxyphenylglycol and Major Affective Disorders: A Replication and New Findings
Muscettola et al.
Arch Gen Psychiatry 1984;41:337-342.
ABSTRACT  

Plasma Cortisol Responses to Clonidine in Depressed Patients and Controls: Evidence for a Possible Alteration in Noradrenergic-Neuroendocrine Relationships
Siever et al.
Arch Gen Psychiatry 1984;41:63-68.
ABSTRACT  

CSF and Urinary Biogenic Amines and Metabolites in Depression and Mania: A Controlled, Univariate Analysis
Koslow et al.
Arch Gen Psychiatry 1983;40:999-1010.
ABSTRACT  

Endogenous inhibitors of monoamine oxidase present in human cerebrospinal fluid
Becker et al.
Science 1983;221:476-478.
ABSTRACT  

CSF Prostaglandin Levels in Depressed and Schizophrenic Patients
Linnoila et al.
Arch Gen Psychiatry 1983;40:405-406.
ABSTRACT  

High Correlation of Norepinephrine and Its Major Metabolite Excretion Rates
Linnoila et al.
Arch Gen Psychiatry 1982;39:521-523.
ABSTRACT  

Biochemical markers identify mental states
Maugh
Science 1981;214:39-41.
 

Psychiatry
Glass and Freedman
JAMA 1981;245:2218-2220.
ABSTRACT  

Conversion of MHPG to Vanillylmandelic Acid: Implications for the Importance of Urinary MHPG
Blombery et al.
Arch Gen Psychiatry 1980;37:1095-1098.
ABSTRACT  

Plasma Free and Conjugated MHPG in Psychiatric Patients: A Pilot Study
Sweeney et al.
Arch Gen Psychiatry 1980;37:1100-1103.
ABSTRACT  

Subtypes of Depression Based on Excretion of MHPG and Response to Nortriptyline
Hollister et al.
Arch Gen Psychiatry 1980;37:1107-1110.
ABSTRACT  

Alterations in brain norepinephrine metabolism induced by environmental stimuli previously paired with inescapable shock
Cassens et al.
Science 1980;209:1138-1140.
ABSTRACT  

Psychiatry
Freedman
JAMA 1979;241:1373-1375.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.